In 2007, the United States federal government recovered $1.54 billion for fraud in the health care industry. The government's unwavering and continuing commitment to enforcement and criminal actions compel the need for a stronger provider understanding of the regulatory framework within which corporate-provider relations must be structured.
This commentary aims to review briefly the need for such education in order to protect providers from legal action and offers a straightforward, proactive compliance approach to optimize patient care and technological innovation while maintaining appropriate remuneration.
Get full access to this article
View all access options for this article.
References
1.
The Bhagavad Gita. Translated by JuanMascaró. London, England, UK: Rider and Company;1962. p. 55
American Medical Association Opinions: (September 28, 2005) E-8.0315 Managing Conflicts of Interest in the Conduct of Clinical Trials. Retrieved February 15, 2008 from http://www.ama-assn.org/ama/pub/category/8471.html
4.
ThompsonDF. Understanding financial conflicts of interest.N Engl J Med.1993;329(8):573–6
5.
BocellaK. “Penn tells top director: no moonlighting.”Philadelphia Inquirer, Feb. 1, 2008, pages B1 and B4
